Clinical trial
Umbilical Cord Arterial Eucapnic pH Compared With Arterial pH and Base Deficit as Predictor of Severe Adverse Outcomes Among Term Neonates
NCT03866876 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Umbilical Cord Arterial Eucapnic pH Compared With Arterial pH and Base Deficit as Predictor of Severe Adverse Outcomes Among Term Neonates
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 1, 2018
- Completion date
- April 30, 2019
- Enrollment
- 36,435 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neurologic complication